Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GSK
GSK
Glaxo’s Melanoma Cocktail Helps Almost All Patients In First Trial
Bloomberg
Sun, 06/5/11 - 10:36 am
GSK
melanoma
New GSK lung drug hits most targets in two studies
Yahoo/Reuters
Fri, 06/3/11 - 09:18 am
GSK
Relovair
Theravance
COPD
South Carolina AG Sues Glaxo Over Avandia
Pharmalot
Wed, 06/1/11 - 08:01 am
South Carolina
GSK
diabetes
lawsuits
Avandia
Pozen sues, saying patent infringed
Bizjournals.com
Wed, 06/1/11 - 07:48 am
Pozen
patents
GSK
migraines
Sun Pharma
Treximet
Drugmakers Face Patent Cliff Generics
Yahoo/InvestorsBusinessDaily
Wed, 06/1/11 - 07:46 am
patents
generics
GSK
Bristol-Myers Squibb
AstraZeneca
Pfizer
Eli Lilly
Merck
Forest Labs
Teva Pharmaceuticals
Abbott Laboratories
Amarin taps suppliers for 'aggressive' launch
Fierce Pharma
Tue, 05/31/11 - 01:52 pm
AMR101
Amarin
GSK
Lovaza
The Biggest Gift Biotechs Can Give to Investors
Motley Fool
Tue, 05/31/11 - 12:36 pm
investors
biotech
Vertex Pharmaceuticals
Exelixis
CytRx
GSK
Novavax
JNJ
Pfizer
Biogen Idec
Seattle Genetics
Immunogen
Alnylam
7 Dividend Winners in Big Pharma
Seeking Alpha
Tue, 05/31/11 - 10:56 am
Abbott Laboratories
AstraZeneca
GSK
dividends
JNJ
Merck
Novartis
Pfizer
It May Be Time for Amylin and Lilly to Head to Divorce Court
Seeking Alpha
Fri, 05/27/11 - 10:50 am
Eli Lilly
Amylin
restraining order
Alkermes
Bristol-Myers Squibb
Elan
GSK
JNJ
Lexicon Pharmaceuticals
Novo Nordisk
Takeda
6 Significant Dividend Yields in the Healthcare Industry
Seeking Alpha
Thu, 05/26/11 - 11:15 am
dividends
Abbott Laboratories
Bristol-Myers Squibb
GSK
JNJ
Pfizer
Novartis
Roche Leads Deadly Skin Cancer Turnaround as Dozen Drugs Coming
Bloomberg
Wed, 05/25/11 - 09:28 am
Roche
skin cancer
melanoma
vemurafenib
GSK
Bristol-Myers Squibb
Daiichi Sankyo
Yervoy
Emerging-Markets Business Offsets Generics: Glaxo CEO
CNBC
Wed, 05/25/11 - 07:59 am
GSK
emerging markets
Andrew Witty
Risk-Reward Balanced at HGSI
Yahoo/Zacks.com
Tue, 05/24/11 - 08:17 pm
Human Genome Sciences
GSK
Novartis
lupus
Benlysta
The Big Winner of the EU Drug Approval Bonanza
Motley Fool
Sat, 05/21/11 - 11:05 am
Benlysta
Human Genome Sciences
Vibativ
Theravance
GSK
Victrelis
Merck
Xgeva
Amgen
Yervoy
Bristol-Myers Squibb
Fampyra
Acorda Therapeutics
Biogen Idec
Glaxo’s Avandia Sales to Stop in U.S. Retail Pharmacies
Bloomberg
Thu, 05/19/11 - 09:43 am
Avandia
GSK
diabetes
Avandia — When A Drug Is On The Market, But Not Really
Forbes
Wed, 05/18/11 - 06:34 pm
diabetes
Avandia
GSK
AstraZeneca: The Street Is too Pessimistic on This High Dividend Big Pharma Stock
Seeking Alpha
Tue, 05/17/11 - 08:52 pm
AstraZeneca
GSK
Merck
Bristol-Myers Squibb
Isis Earns $3 Million Payment as Collaboration With GSK Expands
Yahoo
Mon, 05/16/11 - 11:45 am
GSK
milestone payments
Isis Pharmaceuticals
GSK, University of Manchester & AstraZeneca create Manchester Collaborative Centre for Inflammation Research
pharmabiz
Sat, 05/14/11 - 01:45 pm
GSK
AstraZeneca
Big Pharma Bets on a Novel Cancer Cure
Bloomberg Businessweek
Fri, 05/13/11 - 10:38 am
cancer
Big Pharma
epigenetics
GSK
Eli Lilly
Novartis
Pages
« first
‹ previous
…
123
124
125
126
127
128
129
130
131
…
next ›
last »